Changes in bone mineral density in rat adjuvant arthritis

Clinical Immunology and Immunopathology

Volumn 84, Issue 2, 1997, Pages 166-170

  Takagi, Toshiki ^a   Tsao, Peter W ^a   Totsuka, Ryuichi ^a   Suzuki, Tatsuo ^a   Murata, Takashi ^a   Takata, Isao ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT;

ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE DENSITY; BONE DESTRUCTION; BONE MINERAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; TIBIA; VERTEBRA;

EID: 0031213637     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4373     Document Type: Article

References (26)

1. Wantnick A. S. The adjuvant arthritic rat: A tool for discovering antiarthritic drugs. Immunopharmacology. 1975;Spectrum, New York. p. 155-171.
2. Francis M. D., Hovancik K., Boyce R. W. NE-58095: A diphosphonate which prevents bone erosion and preserves joint architecture in experiential arthritis. Int. J. Tissue React. 11:1989;239-252.
3. Pearson C. M. Experimental joint disease: Observations on adjuvant-induced arthritis in rats by the injection of mycobacterial adjuvant. Am. J. Pathol. 42:1963;73-95.
4. Segawa Y., Nakamura T., Aota S., Tanaka Y., Yoshida K., Tsuzuike N., Matsuda K. Changes in urinary deoxypyridinoline level and vertebral bone mass in the development of adjuvant-induced arthritis in rats. Bone. 17:1995;57-62.
5. Bonnet J., Zerath E., Picaud N., Lesur C., Mattio A., Tordjman C., Hott M., Marie P. J. Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: Evidence for an early bone formation defect. J. Bone Miner. Res. 8:1993;659-668.
6. Jee W. S. S., Li X. J., Ke H. Z., Li M., Smith R. J., Dunn C. J. Application of computer-based histomorphometry to the quantitative analysis of methylprednisolone-treated adjuvant arthritis in rats. Bone Miner. 22:1993;221-247.
7. Turner R. T., Wakley G. K., Hannon K. S. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J. Orthop. Res. 8:1990;612-617.
8. Takagi T., Yamamoto T., Asano S., Tamaki H. Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats. Calcif. Tissue Int. 52:1993;442-446.
9. Vanderschueren D., Herck E. V., Suiker A. M. H., Visser W. J., Schot L. P. C., Bouillon R. Bone and mineral metabolism in aged male rats: Short and long term effects of androgen deficiency. Endocrinology. 130:1992;2906-2916.
10. Li X. J., Jee W. S. S., Ke H. Z., Mori S., Akamine T. Age-related changes of cancerous and cortical bone histomorphometry in female Sprague-Dawley rats. Cell Material. 1:1991;25-35.
11. Griffin M. G., Kimble R., Hopfer W., Pacifici R. Dual-energy X-ray absorptiometry of the rat: Accuracy, precision, and measurement of bone loss. J. Bone Miner. Res. 8:1993;795-800.
12. Ruegsegger P., Durand E. P., Dambacher M. A. Differental effects of aging and disease on trabecular and compact bone density of the radius. Bone. 12:1991;99-105.
13. Baumgartner W. A., Beck F. W., Lorber A., Person C. M., Whitehouse W. A. Adjuvant disease in rats: Biochemical criteria for distinguishing several phase of inflammation and arthritis. Proc. Soc. Exp. Biol. Med. 45:1974;625-630.
14. Weichman B. M., Chau T. T., Rona G. Histopathologic evaluation of the effects of ectodolac in established adjuvant arthritis in rats: Evidence for reversal of joint damage. Arthritis Rheum. 30:1987;466-470.
15. Minne H. W., Pfeilschifter J., Scharla S., Mutschelknauss S., Schwarz A., Krempien B., Ziegler R. Inflammation-mediated osteopenia in the rat: A new animal model for pathological loss of bone mass. Endocrinology. 115:1984;50-54.
16. Sakito S., Ueki Y., Eguchi K., Kawabe Y., Nagataki S. Serum cytokines in patients with rheumatoid arthritis: Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells. Rheumatol. Int. 15:1995;31-37.
17. Stuart R. A., Littlewood A. J., Maddison P. J., Hall N. D. Elevated serum interleukin-6 levels associated with activated disease in systemic connective tissue disorders. Clin. Exp. Rheumatol. 13:1995;17-22.
18. Dinarello C. A. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 14:1989;153-205.
19. Black K., Garret R. Chinese hamster ovary cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis, and thrombocytosis in tumor-bearing nude mice. Endocrinology. 128:1991;2657-2659.
20. Robinson D. R., Tashjian A. M., Levine L. Prostaglandin stimulated bone resorption by rheumatoid synovia. J. Clin. Invest. 56:1975;1181-1188.
21. Mizel S. B., Dayer J. M., Krane S. M., Margenhagen S. E. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by purified lymphocyte-activating factor (interleukin 1). Proc. Natl. Acad. Sci. USA. 78:1981;2475-2477.
22. Duncan H. Cellular mechanisms of bone damage and repair in the arthritic joint. J. Rheumatol. 10:1983;29-37.
23. Kennedy A. C., Smith D. A., Buchanan W. W., Anderson J. B., Jasani M. K. Bone loss in patients with rheumatoid arthritis. Scand. J. Rheumatol. 4:1975;73-79.
24. Ambrook P. N., Eisman J. A., Champion G. D., Yeates M. G., Pocock N. A., Eberl S. Determinations of axial bone loss in rheumatoid arthritis. Arthritis Rheum. 30:1987;721-728.
25. Hancock D. A., Asiedu-Offei S., Atkinson P. J., Reed G. W., Wright V. Femoral bone mass in patients with rheumatoid arthritis and osteoarthrosis. Rheumatol. Rehab. 17:1978;65-71.
26. Tuukkanen J., Wallmark B., Jalovaara P., Takala T., Sjogren S., Vaananen K. Changes induced in growing rat bone by immobilization and remobilization. Bone. 12:1991;113-118.